Tech Company Financing Transactions
Highland Therapeutics Funding Round
Private investors joined a $25 million funding round for Highland Therapeutics. This VC investment round was announced on 10/16/2014.
Transaction Overview
Company Name
Announced On
10/16/2014
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Highland Therapeutics intends to use new funds, among other things, through its wholly owned subsidiary Ironshore Pharmaceuticals & Development, Inc., to complete the clinical development of HLD-200 (under development for the treatment of symptoms associated with ADHD) through to a New Drug Application, to conduct a Phase IIB/III study of HLD-100 (amphetamine), and to expand manufacturing capacity and to pursue pipeline expansion opportunities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
101 College St. 200
Toronto ON, M5G 1L7
Canada
Toronto ON, M5G 1L7
Canada
Phone
Website
Email Address
Not Recorded
Overview
At Highland Therapeutics we strive to create meaningful improvements in everyday life with innovations that go beyond simple convenience.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Lickrish
Chief Financial Officer
Nelson Isabel
Browse more venture capital transactions:
Prev: 10/16/2014: Quantopian venture capital transaction
Next: 10/16/2014: Paintzen venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs